Press Release

DNA/RNA Sample Extraction and Isolation Market to Grow with a CAGR of 6.78% through 2028

Rapid growth of diagnostic applications is expected to drive the Global DNA/RNA Sample Extraction and Isolation Market growth in the forecast period, 2024-2028.

 

According to TechSci Research report, “DNA/RNA Sample Extraction and Isolation Market – Global Industry Size, Share, Trends, Competition Forecast & Opportunities, 2028”, the Global DNA/RNA Sample Extraction and Isolation Market stood at USD 2.46 billion in 2022 and is anticipated to grow with a CAGR of 6.78% in the forecast period, 2024-2028. The Global DNA/RNA Sample Extraction and Isolation Market is witnessing robust growth, driven by a confluence of factors that are transforming the landscape of life sciences and biotechnology. The isolation and extraction of DNA and RNA molecules from biological samples are fundamental processes underpinning numerous applications, including genomics, diagnostics, forensics, and personalized medicine. Genomic research has seen remarkable advancements over the past decade. The ability to decode and analyze the genetic code of organisms, including humans, has opened up new horizons in understanding diseases, developing targeted therapies, and identifying genetic markers for various conditions. The need for high-quality DNA/RNA samples has never been greater, and this drives the demand for cutting-edge extraction and isolation technologies.

The diagnostic landscape has been transformed by molecular diagnostics, which rely heavily on DNA and RNA analysis. Rapid and accurate disease diagnosis is possible through the detection of specific genetic markers, making early intervention and targeted therapies a reality. The rise in diagnostic applications, particularly in areas like cancer detection and infectious disease monitoring, is a significant driver of the market.

Chronic diseases, such as cancer and cardiovascular conditions, continue to be a major global health concern. DNA/RNA sample extraction and isolation are essential in understanding the genetic basis of these diseases, which, in turn, can lead to the development of more effective treatments and preventative measures. The need to combat the growing burden of chronic diseases is driving investment in this market.

The Global DNA/RNA Sample Extraction and Isolation Market is segmented into End User, Technology, Application, Product Type, Regional Distribution, And Company.

Based on the Application, Cancer emerged as the dominant segment in the global market for Global DNA/RNA Sample Extraction and Isolation Market in 2022. PCR is a fundamental technique in molecular biology, genetics, and diagnostic testing. It is widely used across diverse fields, from basic research to clinical diagnostics. As a cornerstone technology, PCR is essential for DNA/RNA amplification, making it a highly demanded application. PCR has a broad spectrum of applications, including genetic testing, pathogen detection, genotyping, and gene expression analysis. Its versatility and adaptability to various research and diagnostic needs make it a popular choice among scientists and clinicians. PCR is known for its high sensitivity and specificity, allowing the detection of minute quantities of DNA or RNA. This level of accuracy is crucial for applications such as disease diagnosis, where even trace amounts of genetic material can provide critical insights. PCR provides rapid results, often within hours, which is valuable for applications where timely information is essential. This speed is particularly advantageous in clinical diagnostics, where quick and accurate results can impact patient care decisions. The development of high-throughput PCR technologies, including qPCR (quantitative PCR) and digital PCR, has significantly increased its utility. These advancements enable the simultaneous analysis of multiple samples, making PCR a vital tool for large-scale studies and diagnostics. PCR is a cost-effective technique compared to some other applications, especially when considering the return on investment in terms of the information it provides. Its affordability has contributed to its widespread use in both research and diagnostics.

 

Browse over XX market data Figures spread through XX Pages and an in-depth TOC on "DNA/RNA Sample Extraction and Isolation Market.”

 

Based on the End User, Pharmaceutical and Biotechnology Companies emerged as the dominant segment in the global market for Global DNA/RNA Sample Extraction and Isolation Market in 2022. Pharmaceutical and biotechnology companies heavily rely on DNA/RNA sample extraction and isolation for drug discovery, development, and research. These organizations are continuously engaged in the search for new therapeutic targets, drug candidates, and biomarkers, necessitating a consistent demand for high-quality genetic material. Genomic medicine has gained prominence in the pharmaceutical and biotechnology sectors. These companies use genetic information to develop personalized therapies, identify patient subpopulations for clinical trials, and investigate the genetic basis of diseases. As precision medicine advances, so does the demand for reliable DNA/RNA samples. These companies conduct extensive biological research, which requires access to purified DNA and RNA samples. Understanding the genetic underpinnings of diseases, elucidating cellular processes, and developing biopharmaceuticals are some of the critical areas where genetic material is essential.

Pharmaceutical and biotechnology companies frequently conduct genetic testing and biomarker discovery studies. These applications demand large quantities of DNA and RNA for the identification of genetic markers, assessment of treatment efficacy, and the development of companion diagnostics.

North America emerged as the dominant player in the Global DNA/RNA Sample Extraction and Isolation Market in 2022, holding the largest market share. The United States and Canada are home to numerous world-renowned research institutions, universities, and biotech hubs. These institutions are at the forefront of genomics research, precision medicine, and drug discovery, all of which heavily rely on DNA/RNA sample extraction and isolation. The region's strong emphasis on R&D activities fuels the need for high-quality genetic material. North America houses a substantial number of pharmaceutical and biotechnology companies that are engaged in drug discovery, development, and genomic medicine. These industries have a consistent demand for DNA/RNA samples, underpinning the growth of the sample extraction and isolation market. Clinical diagnostics play a significant role in North America's healthcare system. The demand for accurate and reliable DNA/RNA samples is particularly high in diagnostics for genetic diseases, infectious diseases, and cancer. The availability of advanced diagnostic services and a strong regulatory framework contributes to the prominence of DNA/RNA sample extraction and isolation in the region.

 

Major companies operating in Global DNA/RNA Sample Extraction and Isolation Market are:

  • Abnova Corporation.
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.
  • Endress+Hauser AG (Analytik Jena GmbH+Co. KG)
  • F. Hoffmann-La Roche Ltd
  • Illumina, Inc.
  • MACHEREY-NAGEL GmbH & Co. KG
  • Merck KGaA
  • Norgen Biotek Corp.
  • Omega Bio-tek, Inc.

 

Download Free Sample Report

Customers can also request for 10% free customization on this report.

 

 “The Global DNA/RNA Sample Extraction and Isolation Market is poised for significant growth in the coming years. With the continuous evolution of precision medicine, there will be an increasing need for efficient sample preparation methods to support personalized treatment plans. Furthermore, the rapid expansion of molecular diagnostics, coupled with an ever-growing emphasis on genomics research, will fuel the requirement for reliable DNA/RNA samples. The development of high-throughput sequencing technologies, increased access to healthcare, and the emphasis on pandemic preparedness will also contribute to market expansion. Collaborative efforts, technological innovations, and the development of sustainable practices are expected to shape the industry's future.” said Mr. Karan Chechi, Research Director with TechSci Research, a research-based management consulting firm.

DNA/RNA Sample Extraction and Isolation Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Product Type (Consumables, Instruments), By Technology (Silica-Based, Magnetic Particle Technology, Automated Spin Column-Based, Magnetic Bead-Based, Automated Liquid Handling Other Technologies), By Application (PCR, NGS, Cloning, Microarray, Blotting Techniques, Other Applications), By End User (Clinical Diagnostic and Forensic Laboratories, Pharmaceutical and Biotechnology Companies, Contract Research Organizations, Others) Region and Competition”, has evaluated the future growth potential of Global DNA/RNA Sample Extraction and Isolation Market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in Global DNA/RNA Sample Extraction and Isolation Market.

 

Contact

Mr. Ken Mathews

Techsci Research LLC

420 Lexington Avenue, Suite 300,

New York, United States- 10170                   

Tel: +13322586602

Email: [email protected]

Website: www.techsciresearch.com

Relevant News